Friday, November 18, 2022 7:25:34 PM
If you compare NWBO to Kite and Juno you will see that $10-12/share is way too low.
They were CAR-T therapies (living cells like DCVAX) however there are major differences that make NWBO worth way more.
For example, those CAR-T therapies were generating single antigen T-cells instead of the full personalized repertoire.
2nd example, our phase 3 data set opens the door to a biomarker approval for MGMT methylated patients irrespective of tumor location. That market is way larger than attacking cd19 on acute lymphoblastic leukemia.
$40 is not impossible and that doesn't include any exuberance in trading and spikes that are seen in markets.
We need to get biotech sector moving, I've researched enough. Dendritic cell replacement is a staple that should've been offered years ago.
The entire market is pretty pathetic that's what makes the possibility for NWBO even stronger.. Everyone knows the whole market is trash right now.
Look and see for yourself...
A fake ass market is exactly how one can be a market maker and take both sides of every ticker, at all times, and somehow not go bankrupt. They sold you turds everywhere you look. Share prices bleed forever and then rise super quick and then they bleed again forever.
They were CAR-T therapies (living cells like DCVAX) however there are major differences that make NWBO worth way more.
For example, those CAR-T therapies were generating single antigen T-cells instead of the full personalized repertoire.
2nd example, our phase 3 data set opens the door to a biomarker approval for MGMT methylated patients irrespective of tumor location. That market is way larger than attacking cd19 on acute lymphoblastic leukemia.
$40 is not impossible and that doesn't include any exuberance in trading and spikes that are seen in markets.
We need to get biotech sector moving, I've researched enough. Dendritic cell replacement is a staple that should've been offered years ago.
The entire market is pretty pathetic that's what makes the possibility for NWBO even stronger.. Everyone knows the whole market is trash right now.
Look and see for yourself...
A fake ass market is exactly how one can be a market maker and take both sides of every ticker, at all times, and somehow not go bankrupt. They sold you turds everywhere you look. Share prices bleed forever and then rise super quick and then they bleed again forever.
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM




